TCOV
BHVN

Trust Company of Vermont’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Trust Company of Vermont’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-64
Closed -$10K – 1013
2022
Q3 		$10K Hold
64
– – ﹤0.01% 728
2022
Q2 		$9K Buy
+64
New +$8.18K ﹤0.01% 717
2021
Q1 		– Sell
-30
Closed -$3K – 802
2020
Q4 		$3K Hold
30
– – ﹤0.01% 710
2020
Q3 		$2K Hold
30
– – ﹤0.01% 719
2020
Q2 		$2K Buy
+30
New +$1.6K ﹤0.01% 736

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Trust Company of Vermont's BHVN Position: Q4 2022 in Review

Trust Company of Vermont sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 64 shares — an estimated $10K sold.

Trust Company of Vermont first reported a position in BHVN in Q2 2020 and held it in 5 quarters. The position peaked at $10K in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Trust Company of Vermont reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Trust Company of Vermont sold 64 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $10K.
  • Trust Company of Vermont first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2020 and held it in 5 quarters.
  • Trust Company of Vermont's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $10K in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Trust Company of Vermont's 13F filing for Q4 2022, filed 9 Feb 2023.